Polycystic Ovary Syndrome
Conditions
Interventions
Sponsors
Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) They are 20-40 years old and have fertility requirements; (2) Syndrome differentiation of kidney depression and ovulation syndrome of Western medicine accord with PCOS standard of the patients; (3) No ovulation induction drugs including clomiphene citrate were taken within 3 months; (4) After salpingography, the uterus was normal and at least one side of the fallopian tube was unobstructed; (5) Those who can accept follow-up and color Doppler ultrasound examination after treatment; (6) Those who voluntarily receive drug treatment, can return visit on time, and can observe clinical treatment as required; (7) There was no history of serious drug allergy; (8) Willing to cooperate with clinical trials and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) There are other infertility factors: premature ovarian failure, uterine factors, such as gonadal hypoplasia, reproductive tract malformation, organic diseases of reproductive organs (adenomyosis, hysteromyoma, etc.), pelvic inflammatory diseases; hysterosalpingostomy; the factors of immunity and male side were immune factors and male factors; (2) Other diseases with similar clinical and endocrine signs as PCOS, such as thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, androgen secreting tumor, Cushing's syndrome, etc; (3) All kinds of malignant tumors, combined with serious cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system diseases and mental illness; (4) Patients with previous history of clomiphene citrate resistance; (5) They have been exposed to teratogenic radiation, poison or drugs and are in the active stage; (6) Patients with incomplete clinical data are difficult to diagnose; (7) Those who fail to comply with the regulations and are not able to follow up regularly; (8) Those who participated in other clinical studies and influenced the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cycle ovulation rate;Six female sex hormones;Serum monoamine neurotransmitter concentration;OHSS, LUFS cycle incidence; | — |
Countries
China
Contacts
Public ContactLiu Yanfeng
Dongzhimen Hospital, Beijing University of traditional Chinese medicine
Outcome results
None listed